ASMLvsLLY
ASML Holding NV vs Eli Lilly and Co. Real data pulled from the alphactor.ai fundamentals pipeline — valuation, balance-sheet health, momentum, and analyst sentiment side by side.
ASML Holding NV
$1,476.5
+32.85%
Eli Lilly and Co
$919.9
-8.86%
60-day price, rebased to 100
Round-by-round
Valuation upside
-74.10% vs -92.70% to DCF fair value
Balance-sheet strength
Altman Z 13.21 vs 15.74
Fundamental quality
Piotroski 6.00 vs 6.00 (of 9)
Growth + margins
Rule-of-40 34.70 vs -9.10
60-day momentum
+6.30% vs -11.51% price return
Market-cap liquidity
$569.1B vs $884.0B
Verdict
Across 6 categories, ASML takes the edge with 3 wins to 2 (and 1 tie). Neither score is a buy signal on its own: run the full backtest and credibility tests on alphactor.ai before putting money on it.
Backtest a strategy on ASML or LLY
Point-in-time backtests, 8-layer credibility pipeline, conviction scoring — free to start.